Abbott Laboratories (ABT) is listed on NYSE in Pharmaceutical Stocks. It is $112.44, +0.76%, with a $195.8B market cap. RSI is 58.9, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 58.9 Neutral
Market Cap $195.8B
P/E Ratio 184.3x
Volume 6.2M
Fundamentals — 10-Q Q1 2026
Revenue $11.2B
Net Income $1.1B
EPS $0.61
Gross Margin 56.2%
Operating Margin 12.0%
Net Margin 9.6%
Debt / Equity 0.6x
P/E Ratio 184.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Ford Robert B | CHAIRMAN AND CEO | Sell | 398,832 | $115.85 | $46.2M | 2026 Aug 25 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Sell | 5,850 | $109.83 | $642,506 | 2026 Aug 11 |
| Stratton John G | Insider | Buy | 2,000 | $86.82 | $173,640 | 2026 May 7 |
| Starks Daniel J | Insider | Buy | 10,000 | $92.65 | $926,537 | 2026 Apr 27 |
| Boudreau Philip P | EVP AND CFO | Buy | 2,200 | $91.50 | $201,300 | 2026 Apr 23 |
| Shroff Eric | Senior Vice President | Sell | 709 | $115.58 | $81,946 | 2026 Mar 2 |
| Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | Sell | 885 | $115.58 | $102,288 | 2026 Mar 2 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Sell | 1,144 | $115.58 | $132,224 | 2026 Mar 2 |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | Sell | 613 | $115.58 | $70,851 | 2026 Mar 2 |
| McCoy John A. Jr. | VICE PRESIDENT AND CONTROLLER | Sell | 585 | $115.58 | $67,614 | 2026 Mar 2 |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | Sell | 263 | $115.58 | $30,398 | 2026 Mar 2 |
| Shroff Eric | Senior Vice President | Sell | 1,586 | $128.02 | $203,040 | 2025 Nov 25 |
| Boudreau Philip P | EVP AND CFO | Sell | 5,550 | $134.55 | $746,753 | 2025 Aug 8 |
| Blount Sally E. | Director | Sell | 2,600 | $129.66 | $337,116 | 2025 Apr 30 |
| Earnhardt Lisa D | EVP AND GROUP PRESIDENT | Sell | 91,367 | $133.83 | $12.2M | 2025 Mar 7 |
| McCoy John A. Jr. | VICE PRESIDENT AND CONTROLLER | Sell | 562 | $138.17 | $77,652 | 2025 Mar 3 |
| Moreland Mary K | EXECUTIVE VICE PRESIDENT | Sell | 791 | $138.17 | $109,292 | 2025 Mar 3 |
| Wainer Andrea F | RETIRED EVP | Sell | 949 | $138.17 | $131,123 | 2025 Mar 3 |
| Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Sell | 1,111 | $138.17 | $153,507 | 2025 Mar 3 |
| Shroff Eric | Senior Vice President | Sell | 562 | $138.17 | $77,652 | 2025 Mar 3 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $27.96 | 64.8 | $159.3B |
| | $244.60 | 46.0 | $15.9B |
| | $794.08 | 58.2 | $82.1B |
| | $255.53 | 48.7 | $451.6B |
| | $45.60 | 41.8 | -- |
Take ABT further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ABT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Abbott Laboratories next reports.
Set alerts on ABT
Get notified when Abbott Laboratories hits your price targets or technical conditions are met.
Get Started Free